Bin Teh Download Headshot

Bin S. Teh, MD

  • Houston Methodist radiation oncologist
  • Vice Chair, Houston Methodist Hospital Department of Radiation Oncology
  • Professor of Radiation Oncology, Houston Methodist Institute for Academic Medicine
  • Professor of Radiation Oncology, Weill Cornell Medical College
Media Contact: Amy Rose , 412.613.1428

Bin S. Teh, MD

Request Interview
Media Contact: Amy Rose , 412.613.1428

Areas of Expertise

  • Bladder cancer
  • Brain cancer
  • Brain tumors
  • Breast cancer
  • Cancer stem cells
  • Eye cancer
  • Gene expression profiling in cancer
  • Kidney cancer
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Metastatic cancer
  • Pancreatic cancer
  • Post-prostatectomy IMRT
  • Prostate cancer
  • Prostate movement study
  • Proteomics in oncology
  •  radio-resistance
  • Testicular cancer

Credentials

MEDICAL SCHOOL
University of Queensland School of Medicine, Austria | 1990
RESIDENCY
Baylor College of Medicine, Houston, Texas | 1998
FELLOWSHIP
Baylor College of Medicine, Houston, Texas | 1999

Publications

Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation
Riveros, C, Ranganathan, S, Haque, W, Huang, E, Xu, J, Kulkarni, GS, Geng, M, Anis, M, Muhammad, T, Chan, KS, Farach, A, Teh, BS, Miles, BJ, Klaassen, Z, Sonpavde, GP, Wallis, CJD & Satkunasivam, R 2024, , Journal of the Canadian Urological Association, vol. 18, no. 2, pp. 17-24. https://doi.org/10.5489/cuaj.8386

Radiation Pneumonitis, Really? A Case of Pulmonary Toxicity from CDK4/6 Inhibitor
Hunt, A, Haque, W, Pino, R, Farach, A, Butler, EB & Teh, BS 2023, , Anticancer Research, vol. 43, no. 8, pp. 3539-3542. https://doi.org/10.21873/anticanres.16531

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma
Barbour, AB, Kirste, S, Grosu, AL, Siva, S, Louie, AV, Onishi, H, Swaminath, A, Teh, BS, Psutka, SP, Weg, ES, Chen, JJ, Zeng, J, Gore, JL, Hall, E, Liao, JJ, Correa, RJM & Lo, SS 2023, , Cancers, vol. 15, no. 14, 3672. https://doi.org/10.3390/cancers15143672

Overview of late complications of radiation therapy in uveal melanoma
Wong, AJ, Schefler, AC & Teh, BS 2023, , Chinese Clinical Oncology, vol. 12, no. 3, 29, pp. 29. https://doi.org/10.21037/cco-22-88


Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2023, , Clinical and Translational Radiation Oncology, vol. 39, 100592, pp. 100592. https://doi.org/10.1016/j.ctro.2023.100592

Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
Burns, EA, Sanchez, CG, Mathur, S, Guerrero, C, Muhsen, IN, Sarfraz, H, Hu, CCA, Tang, CHA, Shah, SS, Tremont, IW, Teh, B, Ganguly, S & Pingali, SRK 2023, , Annals of Hematology, vol. 102, no. 5, pp. 1111-1120. https://doi.org/10.1007/s00277-023-05140-6

A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer
Guan, J, Sun, K, Guerrero, CA, Zheng, J, Xu, Y, Mathur, S, Teh, BS, Farach, A, Zhang, J, Butler, E, Pan, PY, Zsigmond, E, Mei, Z, Mejia, J, Chen, SH, Chang, JC & Bernicker, EH 2023, , International Journal of Radiation Oncology Biology Physics, vol. 118, no. 5, pp. 1531-1540. https://doi.org/10.1016/j.ijrobp.2023.08.044

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
Siva, S, Ali, M, Correa, RJM, Muacevic, A, Ponsky, L, Ellis, RJ, Lo, SS, Onishi, H, Swaminath, A, McLaughlin, M, Morgan, SC, Cury, FL, Teh, BS, Mahadevan, A, Kaplan, ID, Chu, W, Grubb, W, Hannan, R, Staehler, M, Warner, A & Louie, AV 2022, , The Lancet Oncology, vol. 23, no. 12, pp. 1508-1516. https://doi.org/10.1016/S1470-2045(22)00656-8

Comparison of Tumor Size and Gene Expression at Presentation in Uveal Melanoma Patients before and during the COVID-19 Pandemic
Hasegawa, N, Rusakevich, A, Bernicker, E, Teh, BS & Schefler, A 2022, , Ocular Oncology and Pathology, vol. 8, no. 3, pp. 156-160. https://doi.org/10.1159/000524918

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
Mathur, SK, Sun, K, Chang, JC, Niravath, PA, Darcourt, J, Patel, T & Teh, BS 2022, , Clinical Cancer Research, vol. 28, no. 20, pp. 4392-4401. https://doi.org/10.1158/1078-0432.CCR-22-0622

Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma
Chevli, N, Wang, K, Haque, W, Schwartz, MR, Nangia, J, Sasaki, J, Farach, AM, Hatch, SS, Butler, EB & Teh, BS 2022, , Clinical Breast Cancer, vol. 22, no. 7, pp. e807-e817. https://doi.org/10.1016/j.clbc.2022.06.005


A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: The RAD VACCINE MIBC trial
Satkunasivam, R, Lim, K, Teh, BS, Guzman, J, Zhang, J, Farach, A, Chen, SH, Wallis, CJD, Efstathiou, E, Esnaola, NF & Sonpavde, GP 2022, , Future Oncology, vol. 18, no. 25, pp. 2771-2781. https://doi.org/10.2217/fon-2022-0380

Contemporary trends in management of uveal melanoma
Chevli, N, Zuhour, RJ, Messer, JA, Haque, W, Schefler, AC, Bernicker, EH, Chevez-Barrios, P, Farach, AM, Butler, EB & Teh, BS 2022, , Journal of Contemporary Brachytherapy, vol. 14, no. 2, pp. 123-129. https://doi.org/10.5114/jcb.2022.115210

Three-year outcomes of uveal melanoma treated with intra-operative ultrasound-guided iodine-125 brachytherapy using custom-built eye plaques
Wong, AJ, Teh, BS, Nguyen, BT, Pino, R, Bretana, ME, Bernicker, EH, Chevez-Barrios, P, Butler, EB & Schefler, AC 2022, , Journal of Contemporary Brachytherapy, vol. 14, no. 2, pp. 130-139. https://doi.org/10.5114/jcb.2022.115379

Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma
Haque, W, Teh, C, Butler, EB & Teh, BS 2022, , Journal of Neuro-Oncology, vol. 157, no. 1, pp. 137-146. https://doi.org/10.1007/s11060-022-03955-3

Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes
Haque, W, Verma, V, Schwartz, MR, Lim, B, Mangalampalli, N, Butler, EB & Teh, BS 2022, , Clinical Breast Cancer, vol. 22, no. 5, pp. e691-e699. https://doi.org/10.1016/j.clbc.2022.01.006

Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
Puri, A, Mylavarapu, C, Xu, J, Patel, TA, S.Teh, B, Tremont-Lukats, I, Chang, JC & Niravath, P 2022, , Breast Cancer Research and Treatment, vol. 193, no. 3, pp. 613-623. https://doi.org/10.1007/s10549-022-06595-3

A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques
Patel, A, Orakwue, CW, Olek, D, Guzman, JCA, Lim, K, Pino, R, Teh, BS, Butler, B, Satkunasivam, R & Farach, A 2023, , Brachytherapy, vol. 22, no. 2, pp. 195-198. https://doi.org/10.1016/j.brachy.2022.08.014

Languages

  • English
  • Chinese - Cantonese
  • Chinese - Mandarin
  • Hokkien
  • Indonesian
  • Malaysian